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CASE rEPOrT
cologastric fistula with a foreign Body 
in a patient with crohn’s disease
Edward A. McGillicuddy, MDa*; Cassius Iyad Ochoa Chaar, MDa;
Christopher Flynn, MD, PhDb; Gustavo Villalona, MDa; and
Walter E. Longo, MDa
Departments of aSurgery and bPathology, Yale University School of Medicine, New Haven,
Connecticut
Although the medical management of fistulizing Crohn’s disease is improving, a subset of
patients does not respond to maximal medical therapy and is referred for surgical consul-
tation. We report a case of Crohn’s colitis with an ingested foreign body resulting in a colo-
gastric fistula. The patient underwent segmental colectomy and takedown of the cologastric
fistula. At the time of laparotomy, the foreign body was found in the fistulous colonic segment.
The presence of an ingested foreign body likely contributed to a rare fistula that was re-
fractory to medical management.
introduction
Crohn’s disease may present in many
unique ways, including fibrostenotic (stric-
turing) disease, nonperforating-nonstrictur-
ing (inflammatory) disease, and perforating
(fistulizing) disease. Patients with fistulizing
Crohn’s disease tend to have a more aggres-
sive disease course [1,2]. Although antibod-
ies to TNF-alpha are important adjuncts in
the therapy of fistulizing Crohn’s disease,
many fistulae recur and anti-TNFʱ prepara-
tions may be poorly tolerated [3-5]. We pres-
ent a patient with fistulizing Crohn’s disease
complicated by the presence of a long-stand-
ing ingested foreign body. 
report of case
A 23-year-old male with Crohn’s dis-
ease was referred to our surgical clinic. The
patient was diagnosed with Crohn’s disease
at age 7 and had been hospitalized several
times, including one month prior to refer-
ral, with acute Crohn’s disease exacerba-
tions. Infliximab therapy was attempted on
two occasions but subsequently aborted
due to infusion reactions and infectious
complications. At the time of presentation,
the patient described daily bouts of severe
cramping  abdominal  pain  and  frequent
episodes of diarrhea. He noted poor oral in-
take secondary to chronic abdominal pain.
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years prior to this presentation, and this coin
was visible in subsequent radiographic stud-
ies (Figure 1). He had no previous surgical
history.  His  daily  medications  included
ciprofloxacin, metronidazole, a prednisone
taper, methadone (65 mg daily), and 6-mer-
captopurine (75 mg daily). He smoked half
a pack of cigarettes daily. On physical exam,
his body mass index was 17.9 kg/m2, and his
abdomen was minimally tender to palpation.
Laboratory studies were notable only for a
hemoglobin of 11.4 g/dL (normal range 14-
18 g/dL) and a platelet count of 484,000/uL
(normal range 150-300,000/uL). A colono-
scopic examination at this time revealed as-
cending and transverse colonic ulceration
and a tight stricture at 60 centimeters, which
could not be traversed with the colonoscope.
A subsequent single contrast barium enema
revealed  strictures  in  the  ascending  and
transverse colon and a fistula between the
distal transverse colon and the stomach (Fig-
ure 2). 
Given the chronicity and severity of the
patient’s symptoms and the presence of an
ingested foreign body that would decrease
the efficacy of medical management, we
proceeded with operative intervention. The
patient underwent an open extended right
hemicolectomy, partial gastrectomy, and fis-
tula takedown. Intra-operatively, much of
the small bowel was inflamed and edema-
tous, with creeping fat present. The resected
colon was markedly thickened and nodular
with enlarged mesenteric lymph nodes. The
stomach and the omentum were densely ad-
hered to the transverse colon in the area of
the known fistula. A coin was present in the
strictured transverse colon distal to the fis-
tula  tract.  The  final  pathology  revealed
colonic erythema and edema, skip ulcera-
tions, the previously described strictures,
and a dime (Figures 3 and 4). Post-operative
pain control was challenging, given the pa-
tient’s history of long-term narcotic use. He
was discharged from the hospital on post-
operative day seven, following resolution of
an ileus.
The patient noted significant improve-
ment in his symptoms post-operatively. He re-
ported  decreased  abdominal  pain  and
continued medical management with 6-mer-
captopurine. His BMI six months post-opera-
tively was 18.4 kg/m2(from 17.9 kg/m2at the
time of operation).
comment
Pediatric-onset Crohn’s disease is char-
acterized with increased rates of colitis and
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figure 1. Abdominal plain film demonstrates
ingested metallic foreign body.
figure 2. Barium enema demonstrating fis-
tula between the transverse colon and the
stomach; arrow indicates fistula tract.less ileitis compared with
adult onset Crohn’s dis-
ease  [6,7].  Although
many authors have em-
phasized  small  bowel
sparing techniques when
surgical  intervention  is
necessary,  there  are
fewer studies addressing
Crohn’s  colitis  [7,8].
With the progressive na-
ture of Crohn’s disease
pathophysiology,  surgi-
cal intervention for dif-
fuse  Crohn’s  colitis  or
the  complications  of
Crohn’s  colitis  can  be-
come  unavoidable  after
maximal  medical  man-
agement has failed. Some
authors advocate an ag-
gressive  approach  with
distal or diffuse Crohn’s
colitis, including total proctocolectomy in
properly selected patients [9].
Enteric fistulae are a well-described en-
tity in Crohn’s disease, as the transmural,
chronic nature of enteric inflammation re-
sults in tissue erosion into contiguous struc-
tures  [10].  Although  it  is  estimated  50
percent of Crohn’s disease patients develop
some variation of a fistula, gastrocolic fistu-
lae are rare. A review of the literature re-
vealed only 27 examples of gastrocolic fis-
tulae in Crohn’s disease, with this case the
only example of a distal foreign body con-
tributing to fistula patency [10]. Gastrocolic
fistulae are more likely to develop as a re-
sult  of  percutaneous  endoscopic  gastros-
tomy tube placement, benign gastric ulcers,
or gastrointestinal malignancy [11-14]. Typ-
ical symptoms at presentation include ab-
dominal pain, weight loss, and diarrhea, but
115 McGillicuddy: Cologastric fistula in Crohn’s disease
figure 3. Grossly, the resected colon is thickened and edematous. A stricture is present.
The foreign body (a dime) is demonstrated. The stricture is identified with an arrow.
figure 4. Histological examination of surgical specimen (H&E;
40x magnification). There is significant distortion of colonic
crypt architecture with extensive branching of the crypts. A
crypt abscess, a collection of neutrophils in a distended crypt,
is seen adjacent to the muscularis mucosa (arrow head). A
mild infiltrate of plasma cells and other inflammatory cells per-
meates the lamina propria between the crypts (arrows).these are not sufficient to make the diagno-
sis. Feculent vomiting is considered pathog-
nomonic but is present in only one-third of
patients. The most reliable diagnostic tool
for the detection of a gastrocolic fistula is
the barium enema, because retrograde con-
trast administration increases intraluminal
pressure, leading to augmented filling of any
fistulous tracts [11]. Interestingly, intra-ab-
dominal fistulae in Crohn’s patients can take
years or even decades to develop [15]. Al-
though the presence of a foreign body would
likely accelerate fistula formation, there is a
paucity of a data available.  
Undoubtedly, the goals of management
of internal Crohn’s disease fistulae include
permanent closure of fistulous tracts. In the
past, symptom intractability and the lack of
any effective medical therapy resulted in a
high rate of surgical intervention for inter-
nal Crohn’s disease fistulae, with surgery
rates as high as 83 percent. Medical therapy
has recently evolved, and oral antibiotics
(ciprofloxacin and metronidazole) remain a
first line therapy, followed by mercaptop-
urine and azathioprine. The current standard
to induce and maintain remission for fis-
tulizing Crohn’s disease, however, is anti-
TNFʱ  antibody  therapy  [4,16].  The
randomized,  multi-center,  placebo-con-
trolled ACCENT II study evaluated the effi-
cacy of repeated infusions of infliximab in
maintaining fistula closure among patients
who  previously  responded  to  infliximab.
After 54 weeks of therapy, a complete re-
sponse (fistula closed) was observed in 36
percent of the infliximab group and 19 per-
cent of the placebo group (p = 0.009) [5].
Despite advances in the medical ther-
apy, general and colorectal surgeons con-
tinue to play a vital role in the care of the
patient with fistulizing Crohn’s disease. A
subset of patients does not respond to anti-
TNFʱ preparations, and it is important to
note the ACCENT II trial included only pa-
tients who previously responded to inflix-
imab  infusions.  Additionally,  long-term
treatment with anti-TNFʱ antibodies in pa-
tients with rheumatoid arthritis was associ-
ated with increased risk of serious infections
(odds ratio 2.0) and malignancies (odds ratio
3.3). Furthermore, up to 61 percent of pa-
tients develop antibodies to infliximab and
other anti-TNFʱ compounds, necessitating
changes in therapy that may not be cost ef-
fective. Finally, with regard to this particular
patient, it is well recognized that the pres-
ence of a foreign body promotes fistula pa-
tency [17,18].
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